
Arintra Raises $25M Series B for AI Medical Coding
Arintra (US) — Raises $25M Series B led by Define Ventures for its GenAI autonomous medical coding platform, which already processes $5B in annual claim value for health systems.
Daily Digest
Daily Digest
Pomegra Startups
Funding rounds, valuations, acquisitions, and IPOs - daily coverage of the companies shaping the private markets

Arintra (US) — Raises $25M Series B led by Define Ventures for its GenAI autonomous medical coding platform, which already processes $5B in annual claim value for health systems.

Legato (US) exits stealth with $12M from Neotribe Ventures to launch the world's first AI hearing glasses, embedding hearing-assistance tech into eyewear arms at a fraction of traditional hearing-aid prices — founded by the creator of Bose Frames.

Boston biotech Beeline Medicines raises a $126M Series A extension backed by Bain Capital and Bristol-Myers Squibb to advance precision therapies for autoimmune and inflammatory diseases.

Swiss biotech Vaderis Therapeutics closes an oversubscribed $152M Series B led by Goldman Sachs Life Sciences to fund a global Phase 3 trial of engasertib, a potential first-ever approved treatment for rare vascular disorder HHT.

Immunology biotech Boulevard Bio exits stealth with $65M from Deerfield Management to advance a pipeline of multi-specific antibodies for autoimmune diseases including IgA nephropathy.